The prognostic model was first trained on a large dataset of 4106 CT-EGFR+ lung cancer patients to predict EGFR mutation status (wild type vs. mutant) based on the segmented lung region, and subsequently trained to detect COVID-19 in a separate dataset of 1266 patients. This evidence concerns the gene EGFR and COVID-19.